Clinical ResearchEditorial CommentNew Roads, New Ruts: Lessons From Drug-Eluting Stent Restenosis⁎
Editorial Comment
Under an Elsevier user license
open archive
Key Words
angioplasty
antiplatelet therapy
drug-eluting stent(s)
restenosis
Cited by (0)
Dr. Kastrati is a patent holder related to DES; and has received lecture fees/honoraria from Abbott, Biosensors, Biotronik, Cordis, and Medtronic. Dr. Byrne reports that he has no relationships to disclose.
- ⁎
Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.